Quantum Strategy's David Roche says Europe's defense spending needs to increase by at least $200 billion as he discusses the ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...

Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it ...

Baldwin Wallace defeated La Roche (Pa.) 63-53 in Friday’s first-round matchup in the NCAA Division III women's basketball ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Roche will be the first to join Harvard's Enterprise Research Campus in Allston, taking a suite in the first phase of the ...

Pharmaceutical giant Roche announces opening of an innovation centre at Harvard University's corporate research campus.

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Roche Holding AG (OTCMKTS:RHHVF – Get Free Report) saw a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 1,320,000 shares, a decrease ...

Roche's Xolair outperformed oral immunotherapy in a Phase 3 trial for food allergies, showing better tolerance and fewer ...

The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...